WALTHAM, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...
THURSDAY 20 FEBRUARY 2025, INCHEON, South Korea - Celltrion announced new post-hoc analyses of its pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC), at the 20 th European Crohn’s and Colitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback